Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × FED × Celecoxib × Clear all

Phase

Phase 2 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

OTHER 18 NIH 3 NETWORK 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mouth Neoplasms 1

Interventions

stenoparib 1 sargramostim 1 poly ICLC 1 pembrolizumab 1 copanlisib 1 avelumab 1 Yoga 1 Temozolomide 1 PM 01183 1 Immunoglobulins, Intravenous 1 Hydroxychloroquine 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Ethiodized Oil 1 Etanercept 1 Celecoxib 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00953849 2017-03-07

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

VA Office of Research and Development

Phase 1/2 Completed

21 enrolled 10 charts

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡